PMID- 21988274
OWN - NLM
STAT- MEDLINE
DCOM- 20120502
LR  - 20221207
IS  - 1557-8593 (Electronic)
IS  - 1520-9156 (Linking)
VI  - 14
IP  - 1
DP  - 2012 Jan
TI  - ROSSO-in-praxi follow-up: long-term effects of self-monitoring of blood glucose 
      on weight, hemoglobin A1c, and quality of life in patients with type 2 diabetes 
      mellitus.
PG  - 59-64
LID - 10.1089/dia.2011.0116 [doi]
AB  - BACKGROUND: Self-monitoring of blood glucose (SMBG) is a simple tool to monitor 
      the effects of lifestyle change on blood glucose. Recently, the ROSSO-in-praxi 
      Study demonstrated that addition of SMBG to a 12-week lifestyle intervention was 
      associated with significant improvements in glucometabolic control and quality of 
      life in insulin-naive patients with type 2 diabetes mellitus (T2DM). So far it is 
      unknown if this short-term intervention also has long-term effects. Therefore, 
      participants were followed up for a mean period of 2 years. METHODS: Participants 
      (n=327) were asked by mail for current weight, hemoglobin A1c (HbA1c), 
      performance of SMBG, and quality of life (SF36 and CES-D questionnaires). 
      Participants who did not reply were contacted by phone. RESULTS: Two hundred 
      twenty-eight participants (70%) completed the follow-up. During the 12-week 
      lifestyle intervention they had significantly reduced weight (2.2 kg) and HbA1c 
      (0.3%; P<0.001 each). After 2 years they achieved a further reduction of weight 
      (0.2 kg; P<0.001), whereas HbA1c increased again, remaining 0.1% lower than 
      baseline. The numbers of depressed participants remained stable during follow-up, 
      whereas physical and mental health-related quality of life remained better 
      compared with baseline. During follow-up 20% of participants continued SMBG 
      daily, 35% several times a week, and 33% irregularly. It is interesting that 
      participants with daily SMBG demonstrated an HbA1c decrease of 0.3% at time of 
      follow-up, whereas in those who stopped SMBG HbA1c increased by 0.1% (P=0.05). 
      CONCLUSIONS: Integration of a short-term, motivational, and low-cost intervention 
      into basic therapy of T2DM has had beneficial long-term effects on weight and 
      quality of life and, if SMBG was continued daily, also on HbA1c.
FAU - Kempf, Kerstin
AU  - Kempf K
AD  - West-German Centre of Diabetes and Health, Dusseldorf Catholic Hospital Group, 
      Dusseldorf, Germany. kerstin.kempf@wdgz.de
FAU - Kruse, Johannes
AU  - Kruse J
FAU - Martin, Stephan
AU  - Martin S
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20111011
PL  - United States
TA  - Diabetes Technol Ther
JT  - Diabetes technology & therapeutics
JID - 100889084
RN  - 0 (Glycated Hemoglobin A)
SB  - IM
MH  - *Blood Glucose Self-Monitoring/methods
MH  - Body Weight
MH  - Diabetes Mellitus, Type 2/*blood/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Glycated Hemoglobin/*metabolism
MH  - Humans
MH  - Life Style
MH  - Male
MH  - Middle Aged
MH  - Patient Compliance/psychology
MH  - Patient Education as Topic
MH  - *Quality of Life
MH  - Surveys and Questionnaires
MH  - Time
EDAT- 2011/10/13 06:00
MHDA- 2012/05/04 06:00
CRDT- 2011/10/13 06:00
PHST- 2011/10/13 06:00 [entrez]
PHST- 2011/10/13 06:00 [pubmed]
PHST- 2012/05/04 06:00 [medline]
AID - 10.1089/dia.2011.0116 [doi]
PST - ppublish
SO  - Diabetes Technol Ther. 2012 Jan;14(1):59-64. doi: 10.1089/dia.2011.0116. Epub 
      2011 Oct 11.